SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 202.01 |
Enterprise Value ($M) | 277.16 |
Book Value ($M) | 195.02 |
Book Value / Share | 29.98 |
Price / Book | 1.04 |
NCAV ($M) | 55.63 |
NCAV / Share | 8.55 |
Price / NCAV | 3.63 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.43 |
Return on Assets (ROA) | -0.35 |
Return on Equity (ROE) | -0.51 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 15.06 |
Current Ratio | 15.06 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 154.93 |
Assets | 294.32 |
Liabilities | 99.30 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Boxer Capital Management, LLC | 5.50 | ||
13D/A | Curative Ventures V LLC | 36.80 | -94.10 | |
13G | Boxer Capital, LLC | 5.50 | ||
13G | Perceptive Advisors Llc | 5.30 | ||
13G | BML Investment Partners, L.P. | 5.30 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
23,686 | 150,010 | 15.79 | |
19,073 | 105,052 | 18.16 | |
10,031 | 44,862 | 22.36 | |
14,054 | 58,550 | 24.00 | |
(click for more detail) |
Similar Companies | |
---|---|
TGTX – TG Therapeutics, Inc. | THAR – Tharimmune, Inc. |
THTX – Theratechnologies Inc. | TLSA – Tiziana Life Sciences Ltd |
TNFA – TNF Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io